- Cardiac Valve Diseases and Treatments
- Infective Endocarditis Diagnosis and Management
- Cardiovascular Function and Risk Factors
- Cardiac Imaging and Diagnostics
- Cardiac Structural Anomalies and Repair
- Aortic Disease and Treatment Approaches
- Cardiac Arrhythmias and Treatments
- Cardiac pacing and defibrillation studies
- Pulmonary Hypertension Research and Treatments
- Cardiac, Anesthesia and Surgical Outcomes
- Mechanical Circulatory Support Devices
- Cardiovascular Issues in Pregnancy
- Ultrasound in Clinical Applications
- COVID-19 and healthcare impacts
- Coronary Interventions and Diagnostics
- Transplantation: Methods and Outcomes
- Cardiac Arrest and Resuscitation
- Acute Myocardial Infarction Research
- T-cell and B-cell Immunology
- Congenital Heart Disease Studies
- Cardiomyopathy and Myosin Studies
- Heart Failure Treatment and Management
- Cardiac electrophysiology and arrhythmias
- Immune Cell Function and Interaction
- Diabetes Treatment and Management
Montefiore Medical Center
2019-2025
Albert Einstein College of Medicine
2020-2024
The University of Sydney
2011-2023
The Bronx Defenders
2023
Lankenau Medical Center
2023
St. Michael's Hospital
2016-2021
University of Toronto
2016-2021
Laboratoire des Sciences de l'Ingénieur, de l'Informatique et de l'Imagerie
2021
University Hospital of Zurich
2018-2020
University of Zurich
2018-2020
Abstract High expression of CXCR5 is one the defining hallmarks T follicular helper cells (TFH), a CD4 Th cell subset that promotes germinal center reactions and selection affinity maturation B cells. also expressed on 20–25% peripheral blood human central memory (TCM), although definitive function these not fully understood. The constitutive TFH fraction circulating TCM suggests CXCR5+ may represent specialized memory-type programmed for homing to follicles providing help. To verify this...
For patients with symptomatic, severe tricuspid regurgitation (TR), early results of transcatheter valve (TV) intervention studies have shown significant improvements in functional status and quality life associated right-heart reverse remodelling. Longer-term follow-up is needed to confirm sustained these outcomes.
Tricuspid regurgitation (TR) has a poor prognosis and limited treatment options is frequently accompanied by right ventricular (RV) dysfunction. Transcatheter tricuspid valve interventions (TTVI) to reduce TR have been shown be safe feasible with encouraging early results. Patient selection for TTVI remains challenging, the role of function being unknown.The aims this study were 1) investigate survival in TTVI-treated patient population conservatively treated population, 2) evaluate outcome...
Analysis of females carriers the X-linked lymphoproliferative (XLP) trait reveals mechanism underlying exquisite sensitivity XLP patients to often-fatal infection with normally innocuous Epstein-Barr virus.
Abstract Objectives We investigated the durability of tricuspid regurgitation (TR) reduction and clinical outcomes through 12 months after transcatheter valve repair (TTVr) with PASCAL Transcatheter Valve Repair System. Background TTVr has rapidly developed demonstrated favorable acute outcomes, but longer follow‐up data are needed. Methods Overall, 30 patients (age 77 ± 6 years; 57% female) received implantation from September 2017 to May 2019 completed a at months. Results The TR etiology...